LUNG Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $1.83
Market Cap (MRQ) $79M
P/E (TTM) -1.6
EPS (TTM) $-1.16
Revenue (TTM) $87M
ROE (TTM) -88.9%
Debt/Equity (MRQ) 1.0
52W Range $1–$3

LUNG Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$90M
2018-12-31 → 2025-12-31
EPS$-1.33
2020-12-31 → 2025-12-31
Free Cash Flow$-33M
2020-12-31 → 2025-12-31
Net margin-55.0%
2020-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend LUNG 5Y avg Peer Median Verdict
P/E (TTM) -1.65Y avg ≈-8.7 ≈-8.7 · ·
P/S (TTM) 0.95Y avg ≈8.4 ≈8.4 3.9 Undervalued
P/B (MRQ) 2.05Y avg ≈3.4 ≈3.4 3.5 Undervalued
EV / EBITDA -0.85Y avg ≈-4.1 ≈-4.1 · ·
Price / FCF (TTM) -2.65Y avg ≈-11.4 ≈-11.4 · ·
Price / Cash Flow (TTM) -2.65Y avg ≈-12.0 ≈-12.0 · ·
EV / Revenue 0.55Y avg ≈3.3 ≈3.3 · ·
EV / FCF -1.45Y avg ≈-6.9 ≈-6.9 · ·
Price / Tangible Book 1.55Y avg ≈3.5 ≈3.5 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 13.4%
Next Report Nov 10, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Jul 28, 2026 $-0.24 $-0.29 16.0%
March 31, 2026 $-0.33 $-0.33 0.96%
Dec. 31, 2025 $-0.25 $-0.40 37.5%
Sept. 30, 2025 $-0.34 $-0.43 20.3%
June 30, 2025 $-0.38 $-0.38 0.21%
March 31, 2025 $-0.36 $-0.38 5.3%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 18
Metric Trend 20252024202320222021202020192018
Revenue $90M$84M$69M$54M$48M$33M$33M$20M
Cost of Revenue $23M$22M$18M$14M$13M$12M$10M$8M
Gross Profit $67M$62M$51M$40M$36M$21M$22M$12M
R&D Expense $19M$18M$18M$15M$13M$7M$6M$7M
SG&A Expense $101M$102M$95M$83M$70M$46M$34M$20M
Operating Expenses $121M$120M$113M$99M$83M$54M$40M$27M
Operating Income $-54M$-58M$-62M$-59M$-47M$-32M$-18M$-15M
Interest Expense ··$3M$1M$829.0K$3M$2M$3M
Interest Income $3M$5M$6M$2M$400.0K$213.0K$432.0K$21.0K
Other Non-op $790.0K$256.0K$-673.0K$-396.0K$-585.0K$3M$-617.0K$-916.0K
Pretax Income $-53M$-56M$-60M$-59M$-48M$-32M$-20M$-18M
Income Tax $626.0K$500.0K$571.0K$353.0K$343.0K$213.0K$363.0K$12.0K
Net Income $-54M$-56M$-61M$-59M$-49M$-32M$-21M$-18M
EPS (Basic) $-1.33$-1.44$-1.60$-1.59$-1.35$-3.16··
EPS (Diluted) $-1.33$-1.44$-1.60$-1.59$-1.35$-3.16··
Shares (Basic) 40,685,93439,111,07337,974,56737,096,54136,129,40910,184,841··
Shares (Diluted) 40,685,93439,111,07337,974,56737,096,54136,129,40910,184,841··
EBITDA $-54M$-58M$-62M$-59M$-47M$-32M··
Balance Sheet 29
Metric Trend 20252024202320222021202020192018
Cash & Equivalents $70M$71M$84M$102M$148M$232M$15M$4M
Receivables $12M$13M$12M$9M$7M$4M$6M·
Inventory $16M$17M$17M$15M$16M$11M$6M·
Prepaid Expense $4M$4M$4M$4M$5M$3M$2M·
Other Current Assets $491.0K$1M$504.0K$290.0K$347.0K$377.0K$766.0K·
Current Assets $102M$136M$150M$169M$208M$250M$41M·
PP&E (Net) $2M$3M$4M$5M$5M$1M$902.0K·
PP&E (Gross) $9M$9M$9M$8M$7M$3M$2M·
Accum. Depreciation $7M$6M$5M$4M$2M$2M$1M·
Goodwill $2M$2M$2M$2M$2M$2M$2M·
Intangibles ·$0$31.0K$154.0K$277.0K$400.0K$524.0K·
Other Non-current Assets $1M$1M$591.0K$529.0K$731.0K$536.0K$579.0K·
Total Assets $129M$163M$178M$194M$235M$264M$54M·
Accounts Payable $4M$4M$1M$2M$2M$1M$3M·
Accrued Liabilities $15M$16M$16M$13M$13M$9M$9M·
Short-term Debt $106.0K$3M$2M$90.0K$91.0K···
Current Liabilities $20M$24M$23M$18M$18M$13M$14M·
Capital Leases $18M$19M$1M$4M$7M$8M$6M·
Deferred Tax $69.0K$87.0K$114.0K$94.0K$37.0K$62.0K$43.0K·
Other Non-current Liabilities ····$179.0K···
Total Liabilities $75M$77M$59M$40M$42M$38M$36M·
Long-term Debt $37M$37M$37M$17M$17M$17M··
Total Debt $37M$37M$37M·····
Common Stock $42.0K$40.0K$39.0K$38.0K$37.0K$36.0K$2.0K·
Retained Earnings $-522M$-468M$-411M$-350M$-291M$-243M$-211M·
AOCI $2M$2M$3M$2M$2M$2M$1M·
Stockholders' Equity $54M$86M$118M$154M$193M$226M$-187M$-167M
Liabilities + Equity $129M$163M$178M$194M$235M$264M$54M·
Shares Outstanding 41,673,64839,785,96938,516,38337,555,56536,931,76235,693,7532,100,2031,719,446
Cash Flow 15
Metric Trend 20252024202320222021202020192018
Stock-based Comp $21M$23M$22M$16M$11M$3M$364.0K$366.0K
Deferred Tax $-19.0K$-24.0K$26.0K$55.0K$-24.0K$19.0K$-5.0K$-197.0K
Amort. of Intangibles ·$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K
Operating Cash Flow $-32M$-32M$-38M$-45M$-41M$-31M$-21M$-18M
CapEx $452.0K$1M$807.0K$1M$4M$911.0K$720.0K$316.0K
Investing Cash Flow $30M$17M$-2M$-4M$-46M$13M$-14M$200.0K
Debt Issued ·$0$20M$0····
Net Debt Issued ·$0$20M·····
Stock Repurchased ··$0$27.0K$26.0K$21.0K$12.0K$0
Net Stock Activity ··$0$-27.0K$-26.0K$-21.0K··
Financing Cash Flow $833.0K$1M$21M$2M$4M$235M$46M$12M
Net Change in Cash $-1M$-13M$-18M$-47M$-83M$217M$11M$-6M
Taxes Paid $468.0K$556.0K$500.0K$398.0K$322.0K$259.0K$196.0K$226.0K
Free Cash Flow $-33M$-33M$-38M$-46M$-45M$-32M··
Levered FCF ··$-42M$-47M$-46M$-35M··
Profitability 8
Metric Trend 20252024202320222021202020192018
Gross Margin 74.2%74.0%73.9%74.3%73.6%64.8%··
Operating Margin -59.3%-68.9%-90.2%-109.3%-97.7%-98.8%··
Net Margin -59.7%-67.3%-88.6%-109.8%-100.5%-98.5%··
Pretax Margin -59.0%-66.7%-87.8%-109.1%-99.8%-97.8%··
EBITDA Margin -59.3%-68.9%-90.2%-109.3%-97.7%-98.8%··
ROA -37.0%-33.1%-32.8%-27.5%-19.5%-20.3%··
ROE -87.7%-62.7%-49.9%-37.1%-24.6%-334.9%··
ROIC -59.5%-47.3%-40.2%-38.3%-24.6%-14.4%··
Liquidity & Solvency 5
Metric Trend 20252024202320222021202020192018
Current Ratio 5.15.66.59.111.920.0··
Quick Ratio 4.13.44.16.08.818.8··
Debt / Equity 0.70.40.3·····
LT Debt / Equity 0.70.40.3·····
Interest Coverage ··-19.2-55.0-57.1-10.2··
Efficiency 3
Metric Trend 20252024202320222021202020192018
Asset Turnover 0.60.50.40.30.20.2··
Inventory Turnover 1.41.31.10.90.91.4··
Receivables Turnover 7.26.66.67.09.06.7··
Per Share 5
Metric Trend 20252024202320222021202020192018
Book Value / Share $1.30$2.16$3.07$4.10$5.23$6.34··
Revenue / Share $2.22$2.14$1.81$1.45$1.34···
Cash Flow / Share $-0.80$-0.81$-0.99$-1.22$-1.15···
Cash / Share $1.67$1.78$2.17$2.71$4.02$6.49··
EPS (TTM) $-1.33$-1.44$-1.60$-1.59$-1.35$-3.16··
Growth Rates 3
Metric Trend 20252024202320222021202020192018
Revenue YoY 8.0%22.0%28.0%10.8%47.9%···
Revenue CAGR 3Y 19.0%20.1%28.0%·····
Revenue CAGR 5Y 22.6%·······
Valuation (TTM) 14
Metric Trend 20252024202320222021202020192018
Revenue TTM $90M$84M$69M$54M$48M$33M··
Net Income TTM $-54M$-56M$-61M$-59M$-49M$-32M··
Market Cap $92M$270M$491M$317M$1.18B$2.46B··
Enterprise Value $59M$236M$445M·····
P/E -1.7-4.7-8.0-5.3-23.8-21.8··
P/S 1.03.27.25.924.575.3··
P/B 1.73.14.22.16.110.9··
P / Tangible Book 1.83.24.22.16.211.0··
P / Cash Flow -2.8-8.6-13.1-7.0-28.6-80.4··
P / FCF -2.8-8.2-12.8-6.8-26.3-78.1··
EV / EBITDA -1.1-4.1-7.2·····
EV / FCF -1.8-7.2-11.6·····
EV / Revenue 0.72.86.5·····
Earnings Yield -60.2%-21.2%-12.6%-18.9%-4.2%-4.6%··

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $90M $84M $69M $54M $48M
Gross Margin % 74.2% 74.0% 73.9% 74.3% 73.6%
Operating Margin % -59.3% -68.9% -90.2% -109.3% -97.7%
Net Income $-54M $-56M $-61M $-59M $-49M
Diluted EPS $-1.33 $-1.44 $-1.60 $-1.59 $-1.35

Institutional owners (13F) 118 filers · $41.7M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 118
Value held $41.7M
New positions 20
Exited positions 24
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
20 (-3 vs prior Q) 24 (+7 vs prior Q) 39 (0 vs prior Q) 35 (-2 vs prior Q) -5.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
PRIMECAP MANAGEMENT CO/CA/ $5,996,030 4,612,331 14.39% Shares
VANGUARD GROUP INC $5,614,582 2,540,535 13.48% Shares
MORGAN STANLEY $3,799,797 2,922,921 9.12% Shares
Soleus Capital Management, L.P. $3,624,820 2,788,323 8.70% Shares
VANGUARD CAPITAL MANAGEMENT LLC $2,119,285 1,630,219 5.09% Shares
ExodusPoint Capital Management, LP $1,590,622 1,223,555 3.82% Shares
Kent Lake PR LLC $1,500,374 926,157 3.60% Shares
Almitas Capital LLC $1,383,463 1,064,202 3.32% Shares
BlackRock, Inc. $1,147,238 882,490 2.75% Shares
Stonepine Capital Management, LLC $1,060,067 815,436 2.54% Shares
JANE STREET GROUP, LLC $985,700 758,231 2.37% Shares
BRAIDWELL LP $978,303 752,541 2.35% Shares
AQR CAPITAL MANAGEMENT LLC $968,453 744,963 2.32% Shares
Parkman Healthcare Partners LLC $840,533 646,564 2.02% Shares
GEODE CAPITAL MANAGEMENT, LLC $588,714 452,684 1.41% Shares
RENAISSANCE TECHNOLOGIES LLC $552,643 425,110 1.33% Shares
ADAR1 Capital Management, LLC $525,846 404,497 1.26% Shares
DEUTSCHE BANK AG\ $523,011 402,316 1.26% Shares
KOTLER KEVIN $442,000 200,000 1.06% Shares
D. E. Shaw & Co., Inc. $425,787 327,528 1.02% Shares
Jefferies Financial Group Inc. $370,643 285,110 0.89% Shares
CFM WEALTH PARTNERS LLC $343,251 264,039 0.82% Shares
VANGUARD FIDUCIARY TRUST CO $325,664 250,511 0.78% Shares
MARSHALL WACE, LLP $299,959 230,738 0.72% Shares
MILLENNIUM MANAGEMENT LLC $272,423 209,556 0.65% Shares
UBS Group AG $265,269 204,053 0.64% Shares
CITADEL ADVISORS LLC $261,430 201,100 0.63% Put option
Birchview Capital, LP $260,706 200,543 0.63% Shares
Centiva Capital, LP $260,124 200,095 0.62% Shares
NANO CAP NEW MILLENNIUM GROWTH FUND L P $260,000 200,000 0.62% Shares
HSBC HOLDINGS PLC $249,092 193,846 0.60% Shares
STATE STREET CORP $248,951 191,501 0.60% Shares
Squarepoint Ops LLC $238,625 183,558 0.57% Shares
CITADEL ADVISORS LLC $186,425 143,404 0.45% Shares
GOLDMAN SACHS GROUP INC $175,946 135,343 0.42% Shares
JANE STREET GROUP, LLC $160,940 123,800 0.39% Put option
XTX Topco Ltd $153,448 118,037 0.37% Shares
WESTFIELD CAPITAL MANAGEMENT CO LP $143,000 110,000 0.34% Shares
BANK OF MONTREAL /CAN/ $137,745 105,958 0.33% Shares
NORTHERN TRUST CORP $135,355 104,119 0.32% Shares
Redhawk Wealth Advisors, Inc. $129,542 99,648 0.31% Shares
ALGERT GLOBAL LLC $127,832 98,332 0.31% Shares
DIMENSIONAL FUND ADVISORS LP $127,243 97,791 0.31% Shares
TWO SIGMA INVESTMENTS, LP $112,548 86,575 0.27% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $111,020 85,400 0.27% Put option
IEQ CAPITAL, LLC $89,906 69,158 0.22% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $83,685 64,373 0.20% Shares
Quadrature Capital Ltd $83,083 63,910 0.20% Shares
Engineers Gate Manager LP $81,366 62,589 0.20% Shares
MERCER GLOBAL ADVISORS INC /ADV $79,732 61,332 0.19% Shares

Show all 118 institutional owners →

Company insiders 17 insiders · 8 officers · 10 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Glendon E. French III President and CEO Sept. 1, 2026 S 1,137,936 0 10 $-292,323
Steven S. Williamson PRESIDENT AND CEO Sept. 2, 2025 S 358,967 0 0 $0
Derrick Sung COO and CFO Dec. 1, 2025 A 1,335,319 0 0 $0
Mehul Joshi Chief Financial Officer & PAO Sept. 2, 2025 S 208,489 0 0 $0
John Mckune INTERIM CFO March 1, 2024 A 76,210 0 0 $0
Srikanth Radhakrishnan Chief Science & Techn. Officer Sept. 1, 2026 S 316,994 0 12 $-69,508
Geoffrey Beran Rose Chief Commercial Officer Sept. 1, 2026 S 449,832 0 16 $-51,144
David Aaron Lehman General Counsel Sept. 1, 2026 S 361,827 0 16 $-88,505
Tiffany Sullivan Director June 5, 2026 A 115,199 0 0 $0
Georgia Melenikiotou Director June 5, 2026 A 139,714 0 0 $0
Thomas William Burns Director June 5, 2026 A 113,399 0 0 $0
Florin Daniel P Director June 5, 2026 A 133,910 0 1 $-46,409
Dana G Mead Jr. Director June 5, 2026 A 139,714 0 0 $0
Richard Ferrari Director June 5, 2026 A 127,024 0 0 $0
Alissa Hsu Lynch Director June 1, 2023 A 24,530 0 0 $0
Staffan Lindstrand Director Oct. 5, 2020 C 17,004 0 0 $0
BOSTON SCIENTIFIC CORP · July 13, 2021 S 1,488,106 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 3 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.02% 136,242 SH Sept. 11, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 436,553 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 1,152,272 SH Aug. 19, 2026 Daily

LUNG Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 11 analysts BUY
Median target $3.00 +63.9%
3 27.3% Strong Buy
5 45.5% Buy
3 27.3% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

5 analysts · 2026-10-02

Mean target $3.40 +85.8%

← Below all targets Current price $1.83
Low$2.50 Mean$3.40 High$5.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
LUNG $92M -1.7 8.0% -59.7% -87.7% 74.2%
HYPR · -2.3 5.2% -262.3% -93.5% 49.8%
LNSR · -4.1 9.2% · · ·
MBOT $134M -6.9 · · -24.4% ·
OM $67M -0.7 5.1% -68.3% -58.0% 39.1%
VANI $94M -2.9 · · -257.8% ·
STEX $151M -0.3 122.2% 29068.8% -703.0% ·
GUTS $337M -1.2 -22.5% · 3220.3% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 4, 2026